Digital Cognitive Behavior Therapy Program for Suicide Prevention
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Anxiety, Anxiety, Depression, Depression |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/25/2018 |
| Start Date: | August 15, 2018 |
| End Date: | June 30, 2019 |
Thrive-Montana: A Computerized Cognitive Behavior Therapy (cCBT) Program to Reduce Depression, Anxiety, Suicidal Ideation and Behaviors for Rural Montanans
This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy
program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among
adults. The first 450 participants will participate in a randomized waitlist controlled
trial. The remaining 550 participants will be provided the program immediately upon enrolling
program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among
adults. The first 450 participants will participate in a randomized waitlist controlled
trial. The remaining 550 participants will be provided the program immediately upon enrolling
The efficacy of Thrive has been studied among patient and community populations and has shown
to effectively reduce depression and anxiety symptoms among adults with moderate to severe
depression symptoms at baseline.
This study will examine whether Thrive can also reduce suicidal thinking for persons
exhibiting at least moderate depression symptoms. The first phase of the study will implement
a randomized waitlist controlled trial. The second phase of the study will examine the
effects in a open trial. Outcome assessments will occur at baseline, 4- and 8-weeks (12- and
16-weeks for the waitlist group) with a 6-month follow-up assessment for all participants.
to effectively reduce depression and anxiety symptoms among adults with moderate to severe
depression symptoms at baseline.
This study will examine whether Thrive can also reduce suicidal thinking for persons
exhibiting at least moderate depression symptoms. The first phase of the study will implement
a randomized waitlist controlled trial. The second phase of the study will examine the
effects in a open trial. Outcome assessments will occur at baseline, 4- and 8-weeks (12- and
16-weeks for the waitlist group) with a 6-month follow-up assessment for all participants.
Inclusion Criteria:
- Montana resident
- 18+ years old
- Have regular access to broadband internet
- PHQ-9 score greater than 4
Exclusion Criteria:
- No Montana residency
- < 18 years old
- No broadband internet access
- PHQ-9 score less than 5
We found this trial at
1
site
Click here to add this to my saved trials
